Sotalol is a non-selective beta-adrenergic blocker with Class III antiarrhythmic properties used in the treatment of ventricular and supraventricular arrhythmias. It works by blocking β₁ and β₂ receptors and prolonging cardiac action potential, stabilizing heart rhythm. Sotalol API is manufactured under GMP-compliant conditions and is suitable for oral and injectable formulations.

Sotalol API is manufactured and supplied by ARTIS BIOTECH | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.